Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays

Journal of Autoimmunity

Volumn 13, Issue 2, 1999, Pages 267-282

  Roep, Bart O ^a   Atkinson, Mark A ^b   Van Endert, Peter M ^c   Gottlieb, Peter A ^d   Wilson, S Brian ^e   Sachs, Johnny A ^f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FLORIDA   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Autoimmune; Insulin dependent diabetes mellitus; Proliferation; T cell; Workshop

Indexed keywords

AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; TETANUS TOXOID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; BIOASSAY; CELLULAR IMMUNITY; CHILD; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LABORATORY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; T LYMPHOCYTE; WORKSHOP;

EID: 0032880017     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0312     Document Type: Article

References (66)

1. Atkinson M.A., Maclaren N.K. Mechanisms of disease - the pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1994;1428-1436.
2. Roep B.O. T-cell responses to autoantigens in IDDM. The search for the Holy Grail [Review]. Diabetes. 45:1996;1147-1156.
3. Peakman M., Tredger J.M., Davies E.T., Davenport M., Dunne J.B., Williams R., Vergani D. Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique. J. Immunol. Methods. 158:1993;87-94.
4. Smerdon R.A., Peakman M., Hussain M.J., Alviggi L., Watkins P.J., Leslie D.G., Vergani D. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes. 42:1993;127-133.
5. Al-Sakkaf L., Pozzilli P., Tarn A.C., Schwarz G., Gale E.A., Bottazzo G.F. Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes. Diabetologia. 32:1989;322-325.
6. +T-lymphocytes in newly diagnosed type 1 diabetes: a prospective study. Diabet. Med. 7:1990;132-136.
7. Douglas Petersen L., Duinkerken G., Bruining G.J., van Lier R., De Vries R.R.P., Roep B.O. Increased numbers of in vivo activated T-cells in patients with recent onset diabetes mellitus. J. Autoimmun. 9:1996;731-737.
8. Faustman D., Eisenbarth G., Daley J., Breitmeyer J. Abnormal T-lymphocyte subsets in type I diabetes. Diabetes. 38:1989;1462-1468.
9. Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1:1993;215-240.
10. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 37:1994;1154-1158.
11. Mosmann T.R. T lymphocyte subsets, cytokines, and effector functions [Review]. Ann. NY Acad. Sci. 664:1992;89-92.
12. Harrison L.C., Honeyman M.C., De Aizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulindependent diabetes. Lancet. 341:1993;1365-1369.
13. Kallan A.A., Duinkerken G., de Jong R., Van den Elsen P.J., Hutton J.C., Martin S., Roep B.O., De Vries R.R.P. Th1-like cytokine production profile and individual specific alterations in TCRBV-gene usage of T-cells from newly diagnosed type 1 diabetes patients after stimulation with β-cell autoantigens. J. Autoimmun. 10:1997;589-598.
14. Hussain M.J., Maher J., Warnock T., Vats A., Peakman M., Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia. 41:1998;343-349.
15. Sibley R., Sutherland D.E.R., Goetz F., Michael A.F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53:1985;132-144.
16. Bingley P.J., Bonifacio E., Gale E.A. Can we really predict IDDM? [Review]. Diabetes. 42:1993;213-220.
17. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter Olesen H., DeCamilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
18. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Bu D.F., Erlander M.G., Tobin A.J., Maclaren N.K. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339:1992;458-459.
19. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science. 222:1983;1337-1339.
20. Schloot N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Wang T., Eisenbarth G.S. Altered immune response to insulin in newly diagnosed versus insulin treated diabetic patients and healthy control subjects. Diabetologia. 40:1997;564-572.
21. Ellis T.M., Schatz D.A., Ottendorfer E.W., Lan M.S., Wasserfall C., Salisbury P.J., She J.-X., Notkins A.L., Maclaren N.K., Atkinson M.A. The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes. 47:1998;566-569.
22. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.L., Martin S., Martin A., Powers A.C., Prochazka M., Naggert J., Leiter E.H., Eisenbarth G.S. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 92:1993;359-371.
23. Roep B.O., Duinkerken G., Schreuder G.M., Kolb H., de Vries R.R., Martin S. HLA- associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1996;1285-1289.
24. Arden S.D., Roep B.O., Neophytou P.I., Usac E.F., Duinkerken G., de Vries R.R., Hutton J.C. Imogen 38: a novel 38-kd islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97:1996;551-561.
25. Roep B.O., Arden S.D., De Vries R.R.P., Hutton J.C. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature. 345:1990;632-634.
26. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 43:1994;1304-1310.
27. Durinovic-Bello I., Hummel M., Ziegler A.G. Cellular immune respone to diverse islet cell antigens in IDDM. Diabetes. 45:1996;795-800.
28. Roep B.O., Stobbe I., Duinkerken G., Van Rood J.J., Lernmark A., Keymeulen B., Pipeleers D.G., Claas F.H.J., De Vries R.R.P. Auto- and alloimmune reactivity to human islet allografts transplanted to insulin-dependent diabetes mellitus patients. Diabetes. 48:1999;484-490.
29. Bougneres P.F., Carel J.C., Castano L., Boitard C., Gardin J.P., Landais P., Hors J., Mihatsch M.J., Paillard M., Chaussain J.L., Bach J. F. Factors associated with early remission of type 1 diabetes in children treated with cyclosporine. N. Engl. J. Med. 318:1988;663-670.
30. Harrison L.C., Colman P.G., Dean B., Baxter R., Martin F.I.R. Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes. 34:1985;1306-1308.
31. Lampeter E.F., Homberg M., Quabeck K., Schaefer U.W., Wernet P., Bertrams J., Grossewilde H., Gries F.A., Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 341:1993;1243-1244.
32. Roep B.O., De Vries R.R.P. Surrogate end markers during the first year in recent onset IDDM for showing efficacy of treatment and during preventive trials. Diab. Prevent. Ther. 10:1996;2-3.
33. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.
34. Douglas Petersen L., Van der Keur M., De Vries R.R.P., Roep B.O. Autoreactive and immunoregulatory T-cell subsets in insulin dependent diabetes mellitus. Diabetologia. 42:1999;443-449.
35. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., Thorsby E., Sollid L.M. Gliadin-specific, HLA-DQ(alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178:1993;187-196.
36. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin- dependent diabetes. J. Clin. Invest. 94:1994;2125-2129.
37. Tian J., Lehmann P.V., Kaufman D.L. T cell cross-reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1994;1979-1984.
38. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmitz G., Meinl E., Hummel M., Ziegler A.G., Wank R., Schendel D.J. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99:1997;2405-2415.
39. Arden S.D., Roep B.O., Neophytou P.I., Usac E.F., Duinkerken G., de Vries R., Hutton J.C. Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin. Invest. 97:1996;551-561.
40. Bach J.M., Otto H., Nepom G.T., Jung G., Cohen H., Timsit J., Boitard C., van Endert P.M. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10:1997;375-386.
41. Schloot N.C., Batstra M., Duinkerken G., de Vries R.R.P., Dyrberg T., Chaudhuri A., Behan P.O., Roep B.O. GAD65 specific autoreactive T-cells from a non-diabetic stiff-man syndrome patient. J. Autoimmun. 12:1999;289-296.
42. Ellis T., Schatz D., Ottendorfer E., Wasserfall C., Maclaren N., Atkinson M. Cellular immune reactivities against proinsulin in insulin dependent diabetes [Abstract]. Diabetes. 40:1997;1316.
43. Worsaae A., Hejnaes K., Moody A., Ludvigsson J., Pociot F., Lorenzen T., Dyrberg T. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity. 22:1995;183-189.
44. Miyazaki I., Cheung R.K., Gaedigk R., Hui M.F., van der Meulen J., Rajotte R.V., Dosch H.M. T cell activation and anergy to islet cell antigen in type i diabetes. J. Immunol. 154:1995;1461-1469.
45. Gjertsen H.A., Sollid L.M., Ek J., Thorsby E., Lundin K.E. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand. J. Immunol. 39:1994;567-574.
46. Res P.C., Schaar C.G., Breedveld F.C., Van Eden W., Van Embden J.D., Cohen I.R., De Vries R.R.P. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet. 2:1988;478-480.
47. LaSalle J.M., Tolentino P.J., Freeman G.J., Nadler L.M., Hafler D.A. Early signaling defects in human T-cells anergized by T- cell presentation of autoantigen. J. Exp. Med. 176:1992;177-186.
48. Petrovsky N., Harrison L.C. HLA-matched control subjects are essential in studies of susceptibility to IDDM. Diabetologia. 38:1995;125-126.
49. Lundin K.E., Bruserud O., Thorsby E. Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM). Pol. Arch. Med. Wewn. 80:1988;144-150.
50. She J.X. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today. 17:1996;323-329.
51. Hanifi Moghaddam P., de Knijff P., Roep B.O., van der Auwera B., Naipal A., Gorus F.K., Schuit F., Giphart M.J. Belgian Diabetes Registry. Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Diabetes. 47:1998;263-269.
52. Nepom G.T. MHC class-II molecules and autoimmunity. Annu. Rev. Med. 9:1991;493-525.
53. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C.L., Jenkins S.C., Palmer S.M., Balfour K.M., Rowe B.R., Farrall M., Barnett A.H., Bain S.C., Todd J.A. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 371:1994;130-136.
54. Roep B.O., Kallan A.A., Duinkerken G., Arden S.D., Hutton J.C., Bruining G.J., de Vries R.R. T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. Diabetes. 44:1995;278-283.
55. Roep B.O. Standardization of T-cell assays in type 1 diabetes. Diabetologia. 42:1999;636-637.
56. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen specific T-lymphocytes. Science. 274:1996;94-96.
57. Conrad B., Weidmann E., Trucco G., Rudert W.A., Behboo R., Ricordi C., Rodriquezrilo H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 371:1994;351-355.
58. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G.F., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA class II molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313:1985;353-360.
59. Foulis A.K., McGill M., Farquharson M.A. Insulitis in type-1 (insulin-dependent) diabetes- mellitus in man - macrophages, lymphocytes, and interferon-gamma containing cells. J. Pathol. 165:1991;97-103.
60. Somoza N., Vargas F., Rouramir C., Vivespi M., Fernandezfigueras M.T., Ariza A., Gomis R., Bragado R., Marti M., Jaraquemada D., Pujol-Borrell R. Pancreas in recent onset insulin-dependent diabetes mellitus - changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153:1994;1360-1377.
61. Keymeulen B., Ling Z., Gorus F.K., Delvaux G., Bouwens L., Grupping A., Hendrieckx C., Pipeleers- Marichal M., Van Schravendijk C., Salmela K., Pipeleers D.G. Implantation of standardized beta-cell grafts in a liver segment of inslin-dependent diabetic patients: graft and recipient characteristics in tow cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia. 41:1998;452-459.
62. Roep B.O., Kallan A.A., Hazenbos W.L., Bruining G.J., Bailyes E.M., Arden S.D., Hutton J.C., De Vries R.R.P. T-cell reactivity to 38 kD insulin-secretory- granule protein in patients with recent-onset type 1 diabetes. Lancet. 337:1991;1439-1441.
63. De Souza N.F., Zanelli E., Wilson B.S., Strominger J.L., Munn S.R., David C.S. Definition of antigenic determinants on glutamic acid decarboxylase molecule in HLA-DQ transgenic mice [Abstract]. Hum. Immunol. 47:1996;151.
64. Payton M.A., Hawkes C.J., Christie M.R. Relationship of the 37,000- and 40,000-m(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ica512). J. Clin. Invest. 96:1995;1506-1511.
65. Cavallo M.G., Fava D., Monetini L., Barone F., Pozzilli P. Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenisis. Lancet. 348:1996;926-928.
66. Ellis T.M., Ottendorfer E., Jodoin E., Salisbury P.J., She J.X., Schatz D.A., Atkinson M.A. Cellular immune responses to beta casein: elevated in but not specific for individuals with type 1 diabetes mellitus. Diabetologia. 41:1998;731-735.